Quercetin as Possible Supportive Therapy for Mild to Moderate Hyperuricemia

Completed 64 enrolled Liaquat University of Medical & Health Sciences University of Urbino "Carlo Bo" · collab

RandomizedParallel-groupOpen-labelSupportive care

Summary

Uric acid, a metabolic byproduct of purine degradation in humans, is a known risk factor for conditions such as gout and type 2 diabetes. Research has shown that supplementation with quercetin can significantly reduce plasma uric acid levels in individuals with mild hyperuricemia, potentially mitigating these associated risks.

Timeline

Start: 2023-10-01
Primary completion: 2024-04-30
Completion: 2024-08-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Berberine Phytosome®	Unknown	730 mg	Oral
Subject	MonakoPure®	Unknown	2.9 mg	Oral
Subject	Quercetin	Small molecule	200 mg	Oral

Indications

No indication recorded.